Literature DB >> 32570

Dopamine-receptor binding and adenylate-cyclase activity in mouse striatal tissue in the supersensitivity phase after neuroleptic treatment.

J Hyttel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 32570     DOI： 10.1007/bf00426624

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  40 in total

1.  Long-term effects of teflutixol on the synthesis and endogenous levels of mouse brain catecholamines.

Authors:  J Hyttel
Journal:  J Neurochem       Date:  1975-11       Impact factor: 5.372

2.  Stimulation by dopamine of adenosine cyclic 3',5'-monophosphate formation in rat caudate nucleus: effect of lesions of the nigro-neostriatal pathway.

Authors:  B K Krueger; J Forn; J R Walters; R H Roth; P Greengard
Journal:  Mol Pharmacol       Date:  1976-07       Impact factor: 4.436

3.  Long-term changes in the sensitivity of pre-and postsynaptic dopamine receptors in mouse striatum evidenced by behavioural and biochemical studies.

Authors:  M P Martres; J Costentin; M Baudry; H Marcais; P Protais; J C Schwartz
Journal:  Brain Res       Date:  1977-11-11       Impact factor: 3.252

4.  Enhancement of methylphenidate-induced stereotypies by repeated administration of neuroleptis.

Authors:  B Fjalland; I Moller Nielsen
Journal:  Psychopharmacologia       Date:  1974-01-11

5.  Methylphenidate antagonism of haloperidol, interaction with cholinergic and anticholinergic drugs.

Authors:  B Fjalland; I Moller Nielsen
Journal:  Psychopharmacologia       Date:  1974-01-11

6.  Rapid development of hypersensitivity of striatal dopamine receptors induced by alpha-methylparatyrosine and its prevention by protein synthesis inhibitors.

Authors:  J Costentin; H Marçais; P Protais; M Baudry; S De La Baume; M P Martres; J C Schwartz
Journal:  Life Sci       Date:  1977-08-01       Impact factor: 5.037

7.  Clozapine: reduction of the initial dopamine turnover increase by repeated treatment.

Authors:  P C Waldmeier; L Maître
Journal:  Eur J Pharmacol       Date:  1976-07       Impact factor: 4.432

8.  Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine.

Authors:  A C Sayers; H R Bürki; W Ruch; H Asper
Journal:  Psychopharmacologia       Date:  1975

9.  [Receptor-blockade and receptor-hypersensitivity following neuroleptic treatment (author's transl)].

Authors:  I M Nielsen; A V Christensen; J Hyttel
Journal:  Arzneimittelforschung       Date:  1976

10.  Reversal of two manifestations of dopamine receptor supersensitivity by administration of L-dopa.

Authors:  A J Friedhoff; K Bonnet; H Tosengarten
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1977-03
View more
  5 in total

1.  Atypical neuroleptics suppress dopaminergic behavioral supersensitivity.

Authors:  C Schremmer; R Morgenstern; H Fink; T Ott
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  In vitro and in vivo disposition of 3H-methiothepin in brain tissues. Relationship to the effects of acute treatment with methiothepin on central serotoninergic receptors.

Authors:  D L Nelson; A Herbet; L Pichat; J Glowinski; M Hamon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

3.  Dopaminergic supersensitivity: influence of dopamine agonists, cholinergics, anticholinergics, and drugs used for the treatment of tardive dyskinesia.

Authors:  A V Christensen; I M Nielsen
Journal:  Psychopharmacology (Berl)       Date:  1979-04-11       Impact factor: 4.530

4.  Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol.

Authors:  T F Seeger; L Thal; E L Gardner
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

5.  Integrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disorders.

Authors:  Hendrik Wesseling; Paul C Guest; Chi-Ming Lee; Erik Hf Wong; Hassan Rahmoune; Sabine Bahn
Journal:  Mol Autism       Date:  2014-07-04       Impact factor: 7.509
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.